PL356929A1 - Sposób syntezy znanej pochodnej tetrazolu - Google Patents

Sposób syntezy znanej pochodnej tetrazolu

Info

Publication number
PL356929A1
PL356929A1 PL01356929A PL35692901A PL356929A1 PL 356929 A1 PL356929 A1 PL 356929A1 PL 01356929 A PL01356929 A PL 01356929A PL 35692901 A PL35692901 A PL 35692901A PL 356929 A1 PL356929 A1 PL 356929A1
Authority
PL
Poland
Prior art keywords
compound
formula
reaction mixture
synthesis
solvent
Prior art date
Application number
PL01356929A
Other languages
English (en)
Other versions
PL198664B1 (pl
Inventor
Janos Fischer
Ildiko Ballo
Endrene Petenyl
Janos Kreidl
Laszlo Czibula
Andras Nemes
Juhasz Ida Deutschne
Papp Eva Werkne
Bagdy Judit Nagyne
Istvan Hegedus
Jenone Farkas
Original Assignee
Richter Gedeon Vegyeszeti Gyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar Rt. filed Critical Richter Gedeon Vegyeszeti Gyar Rt.
Publication of PL356929A1 publication Critical patent/PL356929A1/pl
Publication of PL198664B1 publication Critical patent/PL198664B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cephalosporin Compounds (AREA)
PL356929A 2000-04-21 2001-04-20 Sposób wytwarzania lozartanu potasu PL198664B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0001618A HU222773B1 (hu) 2000-04-21 2000-04-21 Eljárás egy ismert tetrazolszármazék előállítására
PCT/HU2001/000047 WO2001081336A1 (en) 2000-04-21 2001-04-20 Process for the synthesis of a known tetrazol derivative

Publications (2)

Publication Number Publication Date
PL356929A1 true PL356929A1 (pl) 2004-07-12
PL198664B1 PL198664B1 (pl) 2008-07-31

Family

ID=89978280

Family Applications (1)

Application Number Title Priority Date Filing Date
PL356929A PL198664B1 (pl) 2000-04-21 2001-04-20 Sposób wytwarzania lozartanu potasu

Country Status (17)

Country Link
US (1) US6710183B2 (pl)
EP (1) EP1274702B1 (pl)
JP (1) JP2003531203A (pl)
AT (1) ATE259366T1 (pl)
AU (1) AU2001254998A1 (pl)
BG (1) BG65699B1 (pl)
CZ (1) CZ301029B6 (pl)
DE (1) DE60102008T2 (pl)
EA (1) EA004633B1 (pl)
EE (1) EE05064B1 (pl)
ES (1) ES2215130T3 (pl)
HU (1) HU222773B1 (pl)
PL (1) PL198664B1 (pl)
SK (1) SK286740B6 (pl)
TR (1) TR200401058T4 (pl)
UA (1) UA72803C2 (pl)
WO (1) WO2001081336A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21236A (sl) * 2001-05-18 2003-12-31 Aurobindo Pharma Limited Postopek kristalizacije losartan kalija
WO2003093262A2 (en) * 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
AU2003278422A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Amorphous form of losartan potassium
EP1608641A1 (en) * 2003-04-03 2005-12-28 IPCA Laboratories Limited A process for the synthesis of losartan potassium
US6916935B2 (en) * 2003-05-06 2005-07-12 Ipca Laboratories Losartan potassium synthesis
US7345071B2 (en) 2003-05-07 2008-03-18 Ipca Laboratories Limited Process for the synthesis of Losartan potassium
WO2005066158A2 (en) * 2004-01-06 2005-07-21 Ipca Laboratories Limited An improved process for the synthesis of losartan potassium
WO2006050922A1 (en) 2004-11-11 2006-05-18 Lek Pharmaceuticals D.D. Process for the synthesis of tetrazoles
ITTO20060560A1 (it) * 2006-07-27 2008-01-28 S I M S S R L Composti intermedi per la preparazione di antagonisti dell¿angiotensina ii
JO2868B1 (en) * 2006-08-22 2015-03-15 رانبكسي لابوراتوريز ليمتد Inhibitors of metabolic protein protein enzyme
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US11327065B1 (en) * 2021-08-27 2022-05-10 Jubilant Generics Limited Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4221583A1 (de) * 1991-11-12 1993-05-13 Bayer Ag Substituierte biphenylpyridone
US5206374A (en) * 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
JPH08500323A (ja) * 1991-11-18 1996-01-16 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー Ａ▲ｉｉ▼受容体アンタゴニストの合成のためのテトラゾリルフェニルボロン酸中間体
EP0736021A4 (en) * 1993-12-23 1997-04-02 Merck & Co Inc LOSARTAN POLYMORPH AND METHOD FOR PRODUCING FORM II LOSARTAN
EP0754042A4 (en) * 1994-03-29 2004-06-23 Merck & Co Inc TREATING ATHEROSCLEROSIS WITH IMIDAZOLES BLOCKING THE ANGIOTENSIN II RECEPTOR
ES2105939B1 (es) * 1994-08-02 1998-07-01 Uriach & Cia Sa J Nuevos pirazoles con actividad antagonista de la angiotensina ii.

Also Published As

Publication number Publication date
ATE259366T1 (de) 2004-02-15
DE60102008T2 (de) 2004-12-09
EA004633B1 (ru) 2004-06-24
EE200200460A (et) 2003-12-15
JP2003531203A (ja) 2003-10-21
WO2001081336A1 (en) 2001-11-01
ES2215130T3 (es) 2004-10-01
PL198664B1 (pl) 2008-07-31
US6710183B2 (en) 2004-03-23
EE05064B1 (et) 2008-08-15
CZ301029B6 (cs) 2009-10-14
SK286740B6 (sk) 2009-04-06
BG65699B1 (bg) 2009-07-31
US20030078435A1 (en) 2003-04-24
EP1274702A1 (en) 2003-01-15
HU0001618D0 (en) 2000-06-28
UA72803C2 (en) 2005-04-15
BG107031A (en) 2003-08-29
HUP0001618A2 (hu) 2002-11-28
DE60102008D1 (de) 2004-03-18
TR200401058T4 (tr) 2004-06-21
EP1274702B1 (en) 2004-02-11
WO2001081336A8 (en) 2002-08-29
EA200201122A1 (ru) 2003-04-24
HU222773B1 (hu) 2003-10-28
AU2001254998A1 (en) 2001-11-07
SK12892002A3 (sk) 2002-12-03

Similar Documents

Publication Publication Date Title
ZA200202568B (en) Process for the synthesis of silicoaluminophosphate molecular sieves.
NZ598172A (en) Synthesis of boronic ester and acid compounds
AU7551096A (en) Process for the synthesis of curcumin-related compounds
UA83324C2 (ru) Способ получения фторорганических соединений в спиртовых растворителях
BG106786A (en) Process for the preparation of amorphous atorvastatin
AU2001254998A1 (en) Process for the synthesis of a known tetrazol derivative
PL366372A1 (pl) Sposób i związki pośrednie do wytwarzania latanoprostu
MY116862A (en) New processes for preparing pesticidal intermediates
WO2005003374A3 (en) SYNTHESIS OF β-L-2-DEOXY NUCLEOSIDES
PL368722A1 (pl) Sposoby wytwarzania 3-hydroksy-N,1,6-trialkilo-4-okso-1,4-dihydropirydyno-2-karboksyamidu
NZ544004A (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EA200000924A3 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
MXPA01011104A (es) Procedimiento de sintesis de derivados n-(mercaptoail)-aminoacidos a partir de acidos acrilicos alfa substituidos.
EP1199308A3 (en) Process for the preparation of imidazodiazepine intermediates
FR2846325B1 (fr) Nouveau procede de preparation d'un intermediaire de synthese de pesticide
EP0970947A4 (en) METHOD FOR PRODUCING BUTTERIC ACID DERIVATIVES
CA2420847A1 (en) Process for producing erythromycin derivative
EP1484311A4 (en) PROCESS FOR PRODUCING A CHAIN OLIGOLACTIC ACID ESTER
CA2220808A1 (en) Substituted pyridines
IE820273L (en) Preparation of pirbuterol
EP0739885A4 (en) METHOD FOR PRODUCING 3-ISOXAZOLE CARBONIC ACID
AU7206898A (en) Method for producing 1,3-di-substituted 2-nitroguanidines
IL178062A0 (en) Process for preparing cyclohexanediacetic acid monoamide
WO2007070238A3 (en) Processes for the preparation of modafinil and analogs thereof
CA2250578A1 (en) Improved chemical process for preparing amide derivatives of antibiotic a 40926

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120420